Introduction from the chair

It gives me great pleasure to introduce the Human Tissue Authority’s updated strategy for 2019-22 in my capacity as the Interim Chair of the Authority. Our 2019 – 22 strategy builds on the comprehensive evaluation we conducted before developing our last 3-year strategy, and continues to focus on the three key areas of sustainability, resilience, and agility.  Major themes for the next three years will continue to be a renewed focus on our people, our technology, how we collect and use information, and managing our finances.

Read through the latest regulatory alerts and updates issued by the HTA.

This page provides information on the current HTA Strategy and the Business plans that are delivering the strategy each year.

 

The HTA routinely responds to consultations about issues which fall inside our regulatory remit. Read our responses below

Browse our published reports and documents.